Search results for “LOXL2” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 259 patents, we discovered top 11 key players by total patent application. Gilead Biologics, Inc., PharmAkea, Inc., Gilead Sciences, Inc. are dominant in this area. They take 76.06% of the total patent filing.
Gilead Biologics, Inc.
Delaware, United States
Patent: 115
PharmAkea, Inc.
California, United States
Patent: 51
Gilead Sciences, Inc.
California, United States
Patent: 31
Technion Research & Development Foundation Ltd.
Israel
Patent: 17
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 6
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 6
Nordic Bioscience A/S
Hovedstaden, Denmark
Patent: 4
Arresto BioSciences, Inc.
California, United States
Patent: 3
Laboratory Corp. of America Holdings
North Carolina, United States
Patent: 1
Genentech, Inc.
California, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 38 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Institute Of Cancer Research, PharmAkea, Inc., Yonsei Industry-Academic Cooperation Foundation take 57.89% of patent filing during this period.
Institute Of Cancer Research
United Kingdom
Patent: 9
PharmAkea, Inc.
California, United States
Patent: 9
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 4
Nordic Bioscience A/S
Hovedstaden, Denmark
Patent: 4
University of South Carolina
South Carolina, United States
Patent: 2
Case Western Reserve University
Ohio, United States
Patent: 1
Gilead Sciences, Inc.
California, United States
Patent: 1
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Laboratory Corp. of America Holdings
North Carolina, United States
Patent: 1
Queen's University of Belfast
Belfast, United Kingdom
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 38 patents in last 5 years, we discover 7 new entrants. Yonsei Industry-Academic Cooperation Foundation, Nordic Bioscience A/S, University of South Carolina are the most active new entrants in this area.
Yonsei Industry-Academic Cooperation Foundation
South Korea
Patent: 4
Nordic Bioscience A/S
Hovedstaden, Denmark
Patent: 4
University of South Carolina
South Carolina, United States
Patent: 2
Shenyang Amyao Bioengineering Technology R&D Center Co., Ltd.
Liaoning Sheng, China
Patent: 1
Zhongshan Hospital Fudan University
Shanghai Shi, China
Patent: 1
Laboratory Corp. of America Holdings
North Carolina, United States
Patent: 1
Queen's University of Belfast
Belfast, United Kingdom
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 33 patents, we discovered top 8 universities and scientific research institutions by total patent application. Institute Of Cancer Research, Case Western Reserve University, Centre Hospitalier Universitaire de Montpellier are dominant in this area. They take 66.67% of the total patent filing.
Institute Of Cancer Research
United Kingdom
Patent: 13
Case Western Reserve University
Ohio, United States
Patent: 5
Centre Hospitalier Universitaire de Montpellier
France
Patent: 3
University of South Carolina
South Carolina, United States
Patent: 2
Chang Gung University
Taiwan Province, China
Patent: 2
University of Hawaii at Manoa
Hawaii, United States
Patent: 2
Queen's University of Belfast
Belfast, United Kingdom
Patent: 1
Fourth Military Medical University
Hunan Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: